Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes

Completed · Phase 3

Conditions studied: Diabetes, Diabetes Mellitus, Type 2

In brief

This trial is conducted in Europe and the United States of America (USA). The aim of this trial is to compare the use of Insulin Detemir once a day (morning or evening) to NPH Insulin once a day (evening) when added to treatment with oral antidiabetic drugs in patients with Type 2 diabetes.

Key facts

Study ID

NCT00104182

Run by

Novo Nordisk A/S

People needed

503

Starts

2005-02-01

Expected to finish

2006-02-01

Last updated by the study team

2017-01-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes for at least 12 months
• Currently treated with Oral Antidiabetic Drugs
• BMI lesser than or equal to 40 kg/m2
• HbA1c greater than or equal 7.5 and lesser than or equal to 11%

You may not qualify if…

• Proliferative retinopathy or maculopathy
• Recurrent major hypoglycaemia
• uncontrolled hypertension or any disease or condition (such as renal, hepatic or cardiac) that according to the judgement of the Investigator makes the subject unsuitable for participation in the trial

Where it is running

• Novo Nordisk Investigational Site — Mesa, Arizona, United States
• Novo Nordisk Investigational Site — Phoenix, Arizona, United States
• Novo Nordisk Investigational Site — Anaheim, California, United States
• Novo Nordisk Investigational Site — Concord, California, United States
• Novo Nordisk Investigational Site — Fullerton, California, United States
• Novo Nordisk Investigational Site — La Jolla, California, United States
• Novo Nordisk Investigational Site — Los Angeles, California, United States
• Novo Nordisk Investigational Site — Orange, California, United States
• Novo Nordisk Investigational Site — Poway, California, United States
• Novo Nordisk Investigational Site — Denver, Colorado, United States
• Novo Nordisk Investigational Site — Lake Mary, Florida, United States
• Novo Nordisk Investigational Site — Springfield, Illinois, United States
• Novo Nordisk Investigational Site — Fall River, Massachusetts, United States
• Novo Nordisk Investigational Site — Waltham, Massachusetts, United States
• Novo Nordisk Investigational Site — Jefferson City, Missouri, United States
• Novo Nordisk Investigational Site — Las Vegas, Nevada, United States
• Novo Nordisk Investigational Site — Lewiston, New York, United States
• Novo Nordisk Investigational Site — Williamsville, New York, United States
• Novo Nordisk Investigational Site — Grand Forks, North Dakota, United States
• Novo Nordisk Investigational Site — Cincinnati, Ohio, United States
• Novo Nordisk Investigational Site — Dayton, Ohio, United States
• Novo Nordisk Investigational Site — Connellsville, Pennsylvania, United States
• Novo Nordisk Investigational Site — Lancaster, Pennsylvania, United States
• Novo Nordisk Investigational Site — Norristown, Pennsylvania, United States
• Novo Nordisk Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.